Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Cash Flow Statement
Cash Flow Statement
Liaoning Chengda Biotechnology Co Ltd
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Cash Taxes Paid |
(226)
|
(205)
|
(201)
|
(211)
|
(227)
|
(209)
|
(187)
|
(182)
|
(171)
|
(181)
|
(184)
|
(177)
|
(160)
|
(136)
|
|
| Change in Working Capital |
(880)
|
(740)
|
(732)
|
(684)
|
(669)
|
(663)
|
(680)
|
(710)
|
(726)
|
(746)
|
(743)
|
(743)
|
(744)
|
(727)
|
|
| Cash from Operating Activities |
545
N/A
|
573
+5%
|
583
+2%
|
546
-6%
|
617
+13%
|
659
+7%
|
678
+3%
|
677
0%
|
602
-11%
|
547
-9%
|
526
-4%
|
501
-5%
|
506
+1%
|
472
-7%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(693)
|
(545)
|
(517)
|
(512)
|
(482)
|
(539)
|
(583)
|
(552)
|
(492)
|
(432)
|
(351)
|
(362)
|
(346)
|
(376)
|
|
| Other Items |
(2 914)
|
(362)
|
(95)
|
3 402
|
2 465
|
99
|
104
|
(850)
|
564
|
486
|
541
|
200
|
(418)
|
(232)
|
|
| Cash from Investing Activities |
(3 606)
N/A
|
(906)
+75%
|
(612)
+32%
|
2 890
N/A
|
1 984
-31%
|
(440)
N/A
|
(479)
-9%
|
(1 402)
-193%
|
72
N/A
|
55
-24%
|
190
+249%
|
(163)
N/A
|
(764)
-369%
|
(608)
+20%
|
|
| Financing Cash Flow | |||||||||||||||
| Cash Paid for Dividends |
0
|
(416)
|
(416)
|
(416)
|
(416)
|
(416)
|
(416)
|
(416)
|
0
|
(329)
|
(329)
|
(329)
|
0
|
(329)
|
|
| Other |
4 346
|
4 347
|
4 347
|
(5)
|
(6)
|
(6)
|
(31)
|
(106)
|
(123)
|
(151)
|
(131)
|
(56)
|
(39)
|
(11)
|
|
| Cash from Financing Activities |
4 346
N/A
|
3 930
-10%
|
3 931
+0%
|
(422)
N/A
|
(422)
0%
|
(422)
0%
|
(447)
-6%
|
(523)
-17%
|
(539)
-3%
|
(480)
+11%
|
(460)
+4%
|
(385)
+16%
|
(368)
+4%
|
(340)
+8%
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
2
|
2
|
1
|
3
|
1
|
2
|
3
|
2
|
1
|
1
|
1
|
1
|
|
| Net Change in Cash |
1 284
N/A
|
3 597
+180%
|
3 903
+9%
|
3 017
-23%
|
2 180
-28%
|
(201)
N/A
|
(247)
-23%
|
(1 246)
-404%
|
137
N/A
|
123
-10%
|
257
+108%
|
(47)
N/A
|
(625)
-1 242%
|
(475)
+24%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(148)
N/A
|
28
N/A
|
66
+132%
|
35
-47%
|
135
+288%
|
120
-11%
|
95
-21%
|
125
+31%
|
109
-12%
|
116
+6%
|
175
+51%
|
138
-21%
|
160
+16%
|
96
-40%
|
|